Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14519-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14519-1-AP, RRID:AB_2287033
- Product name
- TCF7L1 antibody
- Antibody type
- Polyclonal
- Description
- TCF7L1 antibody (Cat. #14519-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TRIM27 maintains gut homeostasis by promoting intestinal stem cell self-renewal.
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.
Suppression of preadipocyte determination by SOX4 limits white adipocyte hyperplasia in obesity.
The WNT/Ca(2+) pathway promotes atrial natriuretic peptide secretion by activating protein kinase C/transforming growth factor-β activated kinase 1/activating transcription factor 2 signaling in isolated beating rat atria.
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.
Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling.
Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta.
Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility.
Wang J, Zhao D, Lei Z, Ge P, Lu Z, Chai Q, Zhang Y, Qiang L, Yu Y, Zhang X, Li B, Zhu S, Zhang L, Liu CH
Cellular & molecular immunology 2023 Feb;20(2):158-174
Cellular & molecular immunology 2023 Feb;20(2):158-174
Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Ding D, Blee AM, Zhang J, Pan Y, Becker NA, Maher LJ 3rd, Jimenez R, Wang L, Huang H
Nature communications 2023 Aug 3;14(1):4671
Nature communications 2023 Aug 3;14(1):4671
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.
Ma Y, Liu L, Wei Z, Zhu M, Huang L, Wang S, Yi X, Ying F, Zhao S, Cai J, Wang Z, Sun S
Molecular carcinogenesis 2023 Apr;62(4):479-492
Molecular carcinogenesis 2023 Apr;62(4):479-492
Suppression of preadipocyte determination by SOX4 limits white adipocyte hyperplasia in obesity.
He T, Wang S, Li S, Shen H, Hou L, Liu Y, Wei Y, Xie F, Zhang Z, Zhao Z, Mo C, Guo H, Huang Q, Zhang R, Shen D, Li B
iScience 2023 Apr 21;26(4):106289
iScience 2023 Apr 21;26(4):106289
The WNT/Ca(2+) pathway promotes atrial natriuretic peptide secretion by activating protein kinase C/transforming growth factor-β activated kinase 1/activating transcription factor 2 signaling in isolated beating rat atria.
Li ZY, Liu Y, Han ZN, Li X, Wang YY, Cui X, Zhang Y
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2022 Nov 1;26(6):469-478
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2022 Nov 1;26(6):469-478
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.
Wen YC, Liu YN, Yeh HL, Chen WH, Jiang KC, Lin SR, Huang J, Hsiao M, Chen WY
Oncogenesis 2021 Nov 20;10(11):81
Oncogenesis 2021 Nov 20;10(11):81
Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling.
Hübner K, Cabochette P, Diéguez-Hurtado R, Wiesner C, Wakayama Y, Grassme KS, Hubert M, Guenther S, Belting HG, Affolter M, Adams RH, Vanhollebeke B, Herzog W
Nature communications 2018 Nov 19;9(1):4860
Nature communications 2018 Nov 19;9(1):4860
Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta.
Haider S, Meinhardt G, Saleh L, Kunihs V, Gamperl M, Kaindl U, Ellinger A, Burkard TR, Fiala C, Pollheimer J, Mendjan S, Latos PA, Knöfler M
Stem cell reports 2018 Aug 14;11(2):537-551
Stem cell reports 2018 Aug 14;11(2):537-551
Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility.
Meinhardt G, Haider S, Haslinger P, Proestling K, Fiala C, Pollheimer J, Knöfler M
Endocrinology 2014 May;155(5):1908-20
Endocrinology 2014 May;155(5):1908-20
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse brain tissue were subjected to SDS PAGE followed by western blot with 14519-1-AP(TCF7L1 antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human breast cancer using 14519-1-AP(TCF7L1 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TCF7L1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TCF7L1. This antibody recognizes human, mouse, rat antigen. The TCF7L1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.